Biology Reference
In-Depth Information
66. Izumi T, Brown DB, Naidu CV, et al. Two essential but distinct
functions of the mammalian abasic endonuclease. Proc Natl Acad
Sci, USA 2005;
resistance to chemoradiotherapy and poor outcome. Int J Radiat
Oncol Biol Phys 2001;
:27
e
36.
83. Herring CJ, West CM, Wilks DP, et al. Levels of the DNA repair
enzyme human apurinic/apyrimidinic endonuclease (APE1,
APEX, Ref-1) are associated with the intrinsic radiosensitivity of
cervical cancers. Br J Cancer 1998;
50
:5739
e
43.
67. Fung H, Demple B. A vital role for Ape1/Ref1 protein in
repairing spontaneous DNA damage in human cells. Mol Cell
2005;
102
:463
e
70.
68. Walker LJ, Craig RB, Harris AL, Hickson ID. A role for the human
DNA repair enzyme HAP1 in cellular protection against DNA
damaging agents
17
:1128
e
33.
84. Wang D, Xiang DB, Yang XQ, et al. APE1 overexpression is
associated with cisplatin resistance in non-small cell lung cancer
and targeted inhibition of APE1 enhances the activity of cisplatin
in A549 cells. Lung Cancer 2009;
78
and hypoxic
stress. Nucleic Acids Res
:4884
e
9.
69. Chen DS, Olkowski ZL. Biological responses of human apurinic
endonuclease to radiation-induced DNA damage. Ann N Y Acad
Sci 1994;
1994;
22
(3):298
e
304.
85. Kakolyris S, Kaklamanis L, Engels K, et al. Human apurinic
endonuclease 1 expression in a colorectal adenoma-carcinoma
sequence. Cancer Res 1997;
66
:306
e
8.
70. Silber JR, Bobola MS, Blank A, et al. The apurinic/apyrimidinic
endonuclease activity of Ape1/Ref-1 contributes to human
glioma cell resistance to alkylating agents and is elevated by
oxidative stress. Clin Cancer Res 2002;
726
:1794
e
7.
86. Kakolyris S, Kaklamanis L, Engels K, et al. Human AP endonu-
clease 1 (HAP1) protein expression in breast cancer correlates
with lymph node status and angiogenesis. Br
57
J Cancer
:3008
e
18.
71. Ono Y, Furuta T, Ohmoto T, Akiyama K, Seki S. Stable expression
in rat glioma cells of sense and antisense nucleic acids to a human
multifunctional DNA repair enzyme, APEX nuclease. Mutat Res
1994;
8
:1169
e
73.
87. Puglisi F, Barbone F, Tell G, et al. Prognostic role of Ape/Ref-1
subcellular expression in stage I-III breast carcinomas. Oncol Rep
2002;
1998;
77
:11
e
7.
88. Tell G, Pellizzari L, Pucillo C, et al. TSH controls Ref-1 nuclear
translocation in thyroid cells. J Mol Endocrinol 2000;
9
:55
e
63.
72. Wang D, Luo M, Kelley MR. Human apurinic endonuclease 1
(APE1) expression and prognostic significance in osteosarcoma:
enhanced sensitivity of osteosarcoma to DNA damaging agents
using silencing RNA APE1 expression inhibition. Mol Cancer Ther
2004;
315
:383
e
90.
89. Moore DH, Michael H, Tritt R, Parsons SH, Kelley MR. Alter-
ations in the expression of the DNA repair/redox enzyme APE/
ref-1 in epithelial ovarian cancers. Clin Cancer Res 2000;
24
:602
e
9.
90. Bobola MS, Blank A, Berger MS, Stevens BA, Silber JR. Apurinic/
apyrimidinic endonuclease activity is elevated in human adult
gliomas. Clin Cancer Res 2001;
6
:679
e
86.
73. McNeill DR, Lam W, DeWeese TL, Cheng YC, Wilson 3rd DM.
Impairment of APE1 function enhances cellular sensitivity to
clinically relevant alkylators and antimetabolites. Mol Cancer Res
2009;
3
:3510
e
8.
91. Kelley MR, Cheng L, Foster R, et al. Elevated and altered
expression of the multifunctional DNA base excision repair and
redox enzyme Ape1/ref-1 in prostate cancer. Clin Cancer Res
2001;
7
:897
e
906.
74. Chen DS, Law C, Keng P. Reduction of radiation cytotoxicity by
human apurinic endonuclease in a radiation-sensitive Escher-
ichia coli mutant. Radiat Res 1993;
7
:824
e
30.
92. Yang S, Irani K, Heffron SE, Jurnak F, Meyskens Jr FL. Alterations
in the expression of the apurinic/apyrimidinic endonuclease-1/
redox factor-1 (APE/Ref-1) in human melanoma and identifica-
tion of the therapeutic potential of resveratrol as an APE/Ref-1
inhibitor. Mol Cancer Ther 2005;
7
:405
e
10.
75. Wilson 3rd DM, Bennett RA, Marquis JC, Ansari P, Demple B.
Trans-complementation by human apurinic endonuclease (Ape)
of hypersensitivity to DNA damage and spontaneous mutator
phenotype in apn1-yeast. Nucleic Acids Res 1995;
135
:5027
e
33.
76. Hansen WK, Deutsch WA, Yacoub A, Xu Y, Williams DA,
Kelley MR. Creation of a fully functional human chimeric DNA
repair protein. Combining O6-methylguanine DNA methyl-
transferase (MGMT) and AP endonuclease (APE/redox effector
factor
23
:1923
e
35.
93. Hadi MZ, Coleman MA, Fidelis K, Mohrenweiser HW,
Wilson ID. Functional characterization of Ape1 variants identi-
fied in the human population. Nucleic Acids Res 2000;
4
:3871
e
9.
94. Lu J, Zhang S, Chen D, et al. Functional characterization of
a promoter polymorphism in APE1/Ref-1 that contributes to
reduced lung cancer susceptibility. FASEB J; 2009.
95. Li D, Li Y, Jiao L, et al. Effects of base excision repair gene
polymorphisms on pancreatic cancer survival.
28
1
(Ref
1)) DNA repair proteins.
J Biol Chem
:756
e
62.
77. Robertson KA, Bullock HA, Xu Y, et al. Altered expression of
Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells
confers resistance to bleomycin and radiation. Cancer Res
2001;
1998;
273
Int
J Cancer
:1748
e
54.
96. Agachan B, Kucukhuseyin O, Aksoy P, et al. Apurinic/apyr-
imidinic endonuclease (APE1) gene polymorphisms and lung
cancer risk in relation to tobacco smoking. Anticancer Res
2009;
2007;
120
:2220
e
5.
78. Xu Y, Moore DH, Broshears J, Liu L, Wilson TM, Kelley MR. The
apurinic/apyrimidinic endonuclease (APE/ref-1) DNA repair
enzyme is elevated in premalignant and malignant cervical
cancer. Anticancer Res 1997;
61
:2417
e
20.
97. Hu JJ, Smith TR, Miller MS, Mohrenweiser HW, Golden A,
Case LD. Amino acid substitution variants of APE1 and XRCC1
genes associated with ionizing radiation sensitivity. Carcinogenesis
2001;
29
:3713
e
9.
79. Kakolyris S, Giatromanolaki A, Koukourakis M, et al. Nuclear
localization of human AP endonuclease 1 (HAP1/Ref-1) associ-
ates with prognosis in early operable non-small cell lung cancer
(NSCLC). J Pathol 1999;
17
:917
e
22.
98. Su D, Ma S, Liu P, et al. Genetic polymorphisms and treatment
response in advanced non-small cell lung cancer. Lung Cancer
2007;
22
:351
e
7.
80. Puglisi F, Aprile G, Minisini AM, et al. Prognostic significance of
Ape1/ref-1 subcellular localization in non-small cell lung carci-
nomas. Anticancer Res 2001;
189
:281
e
8.
99. Gossage L, Madhusudan S. Current status of excision repair cross
complementing-group 1 (ERCC1) in cancer. Cancer Treat Rev
2007;
56
:4041
e
9.
81. Thomson B, Tritt R, Davis M, Kelley MR. Histology-specific
expression of a DNA repair protein in pediatric rhabdomyosar-
comas. J Pediatr Hematol Oncol 2001;
21
:565
e
77.
100. Suh KW, Kim JH, Kim Do Y, Kim YB, Lee C, Choi S. Which gene
is a dominant predictor of response during FOLFOX chemo-
therapy for the treatment of metastatic colorectal cancer, the
MTHFR or XRCC1 gene? Ann Surg Oncol 2006;
33
:234
e
9.
82. Koukourakis MI, Giatromanolaki A, Kakolyris S, et al. Nuclear
expression of human apurinic/apyrimidinic
23
endonuclease
(HAP1/Ref-1)
in head-and-neck cancer
is associated with
13
:1379
e
85.
